XELJANZ® (tofacitinib) for the Treatment of Moderately to Severely Active Ulcerative Colitis
On May 30th, 2018, the Pfizer corporation, announced that the Food and Drug Administration (FDA) has approved its application to allow for Xeljanz to be used by ulcerative colitis patients who meet certain criteria.
There are some more details listed on the Pfizer website about this new medicinal product of theirs. You can read the full press release here: https://press.pfizer.com/press-release/pfizer-announces-us-fda-approves-xeljanz-tofacitinib-treatment-moderately-severely-act
What would be excellent is for the current and future UC’ers of the world who have experience with Xeljanz (Tofacitinib) to start including their reviews of this on this page, both reviews of how it went, and as well any potential side effects.
Submit your review | |
I started site shortly after being diagnosed in October of 2008 with severe pancolitis (when my whole colon was inflamed).
For me, it was a very rough start with severe symptoms. Getting bounced from medication to medication was not easy or too helpful. But, I did meet another UC’er, changes several parts of my diet, and of course the rest is history.
Leave a comment, ask a question, take advantage of our past experiences here, use the search boxes, they are your friends to0:)
I’ve written 2 different ulcerative colitis ebooks, you can check them out here.
And, the Free eNewsletter, which has important updates can be joined here.
